+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Postoperative Ileus Epidemiology Forecast 2026-2035

  • PDF Icon

    Report

  • 150 Pages
  • May 2026
  • Region: Global
  • Expert Market Research
  • ID: 6252955
Postoperative ileus (POI) is a significant complication following abdominal surgery, with global incidence ranging from 10 % to 30 %, depending on surgical type and definition, as per Ya-Nan Yin et al., 2023. According to the postoperative ileus epidemiology forecast, POI substantially increases patient morbidity, prolongs hospital stay, and escalates healthcare costs worldwide.

Postoperative Ileus Epidemiology Forecast Report Coverage

The analyst's “Postoperative Ileus Epidemiology Forecast Report 2026-2035” offers comprehensive information on the prevalence and demographics of Postoperative Ileus. It projects the future incidence and prevalence rates of postoperative ileus cases across various populations. The study covers age, gender, and type as major determinants of the postoperative ileus population. The report highlights patterns in the prevalence of postoperative ileus over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of postoperative ileus in the 8 major markets.

Regions Covered

  • The United States
  • Germany
  • France
  • Italy
  • Spain
  • The United Kingdom
  • Japan
  • India

Postoperative Ileus Understanding: Disease Overview

Postoperative Ileus (POI) is a transient impairment of gastrointestinal motility that commonly occurs after abdominal or pelvic surgery. It is characterized by delayed passage of flatus and stool, abdominal distension, nausea, vomiting, and intolerance to oral intake. POI results from surgical stress, bowel manipulation, inflammatory responses, opioid analgesic use, and electrolyte imbalances, which disrupt coordinated intestinal peristalsis. It is generally classified into physiologic (expected short-term ileus resolving within 2-3 days) and prolonged or pathologic ileus, which persists beyond the anticipated recovery period and may require medical intervention.

Postoperative Ileus Epidemiology Perspective

The postoperative ileus epidemiology division offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. The analyst provides both current and predicted trends for postoperative ileus epidemiology scenario by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for postoperative ileus and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.
  • According to Habtie Bantider Wubet et al., 2025, the incidence of postoperative ileus (POI) varies by surgery type, ranging from 4% to 32%, with lower rates in non-abdominal procedures and higher rates in orthopedic (5-20%) and thoracic or urologic surgeries (10-15%).
  • As per Ya-Nan Yin et al., 2023, POI incidence after abdominal surgery averages 10% to 15%, but can reach up to 50% in complete staging surgeries for gynecologic cancers, significantly increasing hospital costs and prolonging stays by up to five days.
  • According to Muhammad Bilal et al., 2025, in a study of 149 patients aged 18-60 undergoing exploratory laparotomy, 8.7% developed POI, with a higher occurrence in males (55.7%) and significant associations with longer operative times and hospital stays.
  • As per Gerardo Sarno et al., 2025, obesity (BMI ≥30 kg/m²) among colorectal cancer patients is a growing risk factor, linked to increased POI rates, perioperative morbidity, and higher in-hospital mortality, with 11.8% prevalence reported in laparoscopic resections.
  • POI affects adults across all age groups, with incidence influenced by surgical type, patient comorbidities, and perioperative management, highlighting its global clinical and socioeconomic significance.

Country-wise Postoperative Ileus Epidemiology

The postoperative ileus epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

Building on regional trends, the epidemiology of postoperative ileus (POI) varies across key countries. In the United States, postoperative ileus remains a common postoperative complication, with recent NIH-indexed studies reporting that up to 25% of patients undergoing elective abdominal surgery develop POI, while prolonged POI occurs in approximately 5%-30% of colorectal surgery cases, indicating a substantial and persistent healthcare burden. As per Habtie Bantider Wubet et al., 2025, in the United Kingdom, POI occurs in approximately 7.8% of orthopedic patients, while Italy reports an 8.0% incidence following elective spine surgeries, and France shows a 7.9% incidence in non-abdominal procedures [24-26]. According to Timur Buniatov et al., 2025, Germany sees around 110,000 hospitalizations annually for ileus, with an incidence of 108 per 100,000 individuals [3]. As per Fasika Chanie Animaw et al., 2025, Japan reports a 13.5% occurrence after abdominal surgery [13]. These data highlight the geographic variability in POI, influenced by surgical type, patient demographics, and perioperative care protocols.

Postoperative Ileus: Treatment Overview

Management of postoperative ileus primarily involves supportive and preventive strategies aimed at restoring bowel function. Key measures include early mobilization, early enteral feeding as tolerated, optimization of fluid and electrolyte balance, and minimization of opioid analgesics through multimodal pain management. Nasogastric decompression may be used in cases of significant vomiting or distension. Pharmacologic therapies such as prokinetic agents and peripherally acting mu-opioid receptor antagonists, including alvimopan, may reduce duration in selected patients. Enhanced Recovery After Surgery protocols are widely implemented to prevent and shorten the duration of postoperative ileus.

Key Questions Answered

  • What are the key findings of postoperative ileus epidemiology in the 8 major markets?
  • What will be the total number of patients with postoperative ileus across the 8 major markets during the forecast period?
  • What was the country-wise postoperative ileus epidemiology scenario in the 8 major markets in the historical period?
  • Which country will have the highest number of postoperative ileus patients during the forecast period of 2026-2035?
  • Which key factors would influence the shift in the patient population of postoperative ileus during the forecast period of 2026-2035?
  • What are the currently available treatments for postoperative ileus?
  • What are the risks, signs, symptoms, and unmet needs of postoperative ileus?

Scope of the Postoperative Ileus Epidemiology Report

  • The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of postoperative ileus based on several factors.
  • Postoperative Ileus Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
  • The postoperative ileus report helps to identify the patient population, and the unmet needs are highlighted along with an assessment of the disease's risk and burden.

Table of Contents

1 Preface
1.1 Introduction
1.2 Objectives of the Study
1.3 Research Methodology and Assumptions
2 Executive Summary
3 Postoperative Ileus Market Overview - 8 MM
3.1 Postoperative Ileus Market Historical Value (2019-2025)
3.2 Postoperative Ileus Market Forecast Value (2026-2035)
4 Postoperative Ileus Epidemiology Overview - 8 MM
4.1 Postoperative Ileus Epidemiology Scenario (2019-2025)
4.2 Postoperative Ileus Epidemiology Forecast (2026-2035)
5 Disease Overview
5.1 Signs and Symptoms
5.2 Causes
5.3 Risk Factors
5.4 Guidelines and Stages
5.5 Pathophysiology
5.6 Screening and Diagnosis
6 Patient Profile
6.1 Patient Profile Overview
6.2 Patient Psychology and Emotional Impact Factors
7 Epidemiology Scenario and Forecast - 8 MM (219-2035)
7.1 Key Findings
7.2 Assumptions and Rationale
7.3 Postoperative Ileus Epidemiology Scenario in 8MM (2019-2035)
8 Epidemiology Scenario and Forecast: United States (219-2035)
8.1 Postoperative Ileus Epidemiology Scenario in United States (2019-2035)
9 Epidemiology Scenario and Forecast: United Kingdom (219-2035)
9.1 Postoperative Ileus Epidemiology Scenario in United Kingdom (2019-2035)
10 Epidemiology Scenario and Forecast: Germany (219-2035)
10.1 Postoperative Ileus Epidemiology Scenario in Germany (2019-2035)
11 Epidemiology Scenario and Forecast: France (219-2035)
11.1 Postoperative Ileus Epidemiology Scenario in France (2019-2035)
12 Epidemiology Scenario and Forecast: Italy (219-2035)
12.1 Postoperative Ileus Epidemiology Scenario in Italy (2019-2035)
13 Epidemiology Scenario and Forecast: Spain (219-2035)
13.1 Postoperative Ileus Epidemiology Scenario in Spain (2019-2035)
14 Epidemiology Scenario and Forecast: Japan (219-2035)
14.1 Postoperative Ileus Epidemiology Scenario in Japan (2019-2035)
15 Epidemiology Scenario and Forecast: India (219-2035)
15.1 Postoperative Ileus Epidemiology Scenario in India (2019-2035)
16 Patient Journey17 Treatment Challenges and Unmet Needs18 Key Opinion Leaders (KOL) Insights